Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
A phase 3 trial of Technetium-99m tilmanocept in Breast cancer and Melanoma, run by Navidea Biopharmaceuticals, completed.
Overview
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma is a phase 3 interventional study registered as NCT00671918 by Navidea Biopharmaceuticals, with 186 participants recorded, started 2008-04 and reaching its primary completion in 2009-06. Interventions recorded: Lymphoseek. Conditions recorded: Breast Cancer, Melanoma.
Linked to the drug Technetium-99m tilmanocept because the registry names it among its interventions and Breast cancer and Melanoma among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialBreast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
Shares Navidea Biopharmaceuticals, Technetium-99m tilmanocept, Breast cancer (all types), Melanoma and the tag pipeline.
- TrialEvaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Shares Navidea Biopharmaceuticals, Technetium-99m tilmanocept and the tag pipeline.
- TrialPersonalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Shares Technetium-99m tilmanocept and the tag pipeline.
- TrialImplementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients
Shares Breast cancer (all types) and the tag pipeline.
- TrialCryoablation Versus Lumpectomy in Early-Stage Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.
- TrialPrevention of Persistent Alopecia Following Docetaxel by Means of Scalp Cooling
Shares Breast cancer (all types) and the tag pipeline.
- TrialComparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Shares Breast cancer (all types) and the tag pipeline.
- TrialDiagnostic Accuracy and Safety Study of FES PET/CT in Assessment of ER Status of Recurrent or Metastatic Breast Cancer
Shares Breast cancer (all types) and the tag pipeline.